Issue : The Pharmaceutical Journal, online
Sort by: Newest first Oldest first A-Z Z-A
-
Pharmacists’ role in mental health management: a personal view
Mental health management in pharmacies has always been an issue worth fighting for, and its time has now come.
-
Patient-centred interventions for multimorbidity do not improve quality of life, study shows
Patient-centred interventions to improve care of people with multiple chronic conditions do not improve quality of life or clinical outcomes, according to the findings of a UK study published in The Lancet.
-
Money for NHS transformation spent on cutting deficits, NAO finds
An NHS England scheme to use new models of care to better meet patients’ needs and make savings has failed to achieve its aims, a report by the National Audit Office has found.
-
RPS announces two awards for women in pharmacy
The Royal Pharmaceutical Society has created two prizes for women in pharmacy and pharmaceutical science.
-
Harvinder Sondh appointed director of innovation and enterprise
Source: MAG / The Pharmaceutical Journal Harvinder Sondh is the RPS’s new director of innovation and enterprise
-
Wanted: feedback on how we can improve your revalidation app
Please share your experience of using the RPS MyCPD application to help us make it better for you.
-
Regulator to review Gosport findings following inappropriate opioid painkiller doses
The pharmacy regulator will consider whether any action will be taken following the report into Gosport War Memorial Hospital.
-
Standards must be aligned for high-tech health aids to succeed, NICE conference told
Standards for apps and wearable technologies, agreed by bodies such as NHS England and the Department of Health and Social Care, should be aligned to maximise their health improvement potential, delegates at the National Institute for Health and Care Excellence annual conference were told on 26 June 2018.
-
MHRA will continue to monitor safety of opioid patches after baby's death
The risks associated with fentanyl patches have been reiterated by the UK’s drugs safety watchdog after a baby died when a patch worn by her mother became attached to her skin.
-
NHS drugs bill could hit £20bn by 2021, deputy chief pharmaceutical officer warns
The actual cost of the NHS’s medicine bill is contested but it continues to rise, Bruce Warner, deputy chief pharmaceutical officer at NHS England, told delegates at the National Institute for Health and Care Excellence annual conference.
Show 10 per page20 per page50 per page
